Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. MDW, Longenesis and Bitfury to bring blockchain to medical imaging
  2. FDA grants breakthrough designation to BioDirection Tbit System
  3. What does the future hold for MRI? Find out in the latest issue of Medical Technology
  4. Exploring the past and future of MRI with Avingtrans
  5. How are emerging AI systems revolutionising the way that patients are treated? Find out in the latest issue of Medical Technology

Latest Content

Exploring the past and future of MRI with Avingtrans

To further enhance its status in the MRI space, Avingtrans has acquired Tecmag, a US-based company, which designs and manufacturers consoles and probes for MRI and NMR probs. In the context of this acquisition, Peter Penfold, Avingtrans’ business development director, discussed how the company entered and then consolidated itself in the medical imaging space, as well as industry-wide challenges, innovations and areas predicted to drive growth.

Could a new Alzheimer’s blood test disrupt imaging and spinal fluid methods?

Finding a biomarker in Alzheimer's disease (AD) that translates into clinical meaningfulness has been a real challenge for the field of biomarkers in the central nervous system (CNS). The current way to definitively diagnose AD is through brain scans and tests of cerebrospinal fluid (CSF) that must be collected via lumbar puncture, but these procedures are invasive and expensive.

Latest News

Read our magazine

Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top